ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 509

A Novel Screening Tool Indicative Of Primary Sjogren’s Syndrome Versus Sicca Symptoms

Gerard Dumancas1, Michael Brown2, Indra Adrianto1, Christopher J. Lessard1, Jennifer A. Kelly1, Kiely Grundahl3, Astrid Rasmussen1, R. Hal Scofield4, Courtney Montgomery5 and Kathy L. Sivils1,6, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, oklahoma CIty, OK, 4US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and recruiting

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Sjogren’s syndrome (SS) is a chronic, progressive disease characterized by dry eyes and dry mouth resulting from lymphocytic infiltration of the lacrimal and salivary glands, respectively. Although SS is defined by keratoconjunctivitis sicca and xerostomia (dry eyes and mouth), the full spectrum of disease can involve a complex myriad of systemic symptoms similar to other rheumatic diseases.  The American-European Consensus Group (AECG) classification criteria for SS require serologic and hematologic tests as well as the expertise of at least two clinical specialties for diagnosis.  As such, proper diagnosis of SS is often challenging.

Methods: In order to develop a model to better predict SS, we first assessed the predictive value of a commonly used screening tool, the AECG six-question phone interview, in 379 European American (EA) individuals with dry eyes and mouth using structural equation modeling (SEM) and logistic regression (LR).  Then, using responses to 440 general health and medical history questions in addition to the six-question phone interview from the same participants, we developed a novel predictive model using genetic algorithm (GA), k-nearest neighbor and forward selection model.

Results:

The six-question phone interview, which in our experience results in ~36% classification of SS, yielded an ill-fitting model with low prediction accuracy (~56% under violated assumptions) in silico. Our novel model generated from the general health, medical history questionnaire, and six-question phone interview data obtains an accuracy of ~61% in the test set and ~64% in the unknown set. The generated model considered clinically substantive consisted of 9 questions relating to autoimmunity, difficulty swallowing, mouth/tongue dryness, aching, and disorientation.

Conclusion:

The six-question phone interview, which in our experience results in ~36% classification of SS, yielded an ill-fitting model with low prediction accuracy (~56% under violated assumptions) in silico. Our novel model generated from the general health, medical history questionnaire, and six-question phone interview data obtains an accuracy of ~61% in the test set and ~64% in the unknown set. The generated model considered clinically substantive consisted of 9 questions relating to autoimmunity, difficulty swallowing, mouth/tongue dryness, aching, and disorientation.


Disclosure:

G. Dumancas,
None;

M. Brown,
None;

I. Adrianto,
None;

C. J. Lessard,
None;

J. A. Kelly,
None;

K. Grundahl,
None;

A. Rasmussen,
None;

R. H. Scofield,
None;

C. Montgomery,
None;

K. L. Sivils,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-screening-tool-indicative-of-primary-sjogrens-syndrome-versus-sicca-symptoms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology